Interparfums
IPAR
111.00
-1.85
-1.64%
Interparfums
US · IPAR
#2368 by market cap
Listed 1970
111.00
-1.85
-1.64%
Live - 5344 symbols - heartbeat 292s ago
· 2026-10-07 19:54
After-hours
111.00
0.00%
- Market cap
- 3.55B
- P/E (TTM)i
- 21.22
- P/Bi
- 4.08
- EPSi
- 5.24
- Div yieldi
- 2.88%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on IPAR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.18, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.49% YoY
Margins
- Gross margin
- 63.64%
- Operating margin
- 18.16%
- Net margin
- 11.31%
Key ratios & quality
- Enterprise valuei
- 3.45B
- PEG ratioi
- 1.82
- Altman Z-Scorei
- 7.18
PEG uses trailing P/E against the 3-year net income growth rate (11.66%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 675.57M | 713.51M | 539.01M | 879.52M | 1.09B | 1.32B | 1.45B | 1.49B |
| Gross profit | 427.56M | 445.94M | 330.73M | 556.90M | 694.42M | 839.08M | 927.34M | 947.22M |
| Selling & admin expenses | 332.83M | 341.21M | 260.65M | 406.46M | 492.37M | 587.70M | 648.54M | 676.90M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 94.73M | 104.73M | 70.08M | 150.44M | 202.05M | 251.38M | 278.80M | 270.32M |
| Pretax profit | 95.86M | 105.15M | 69.35M | 151.02M | 194.22M | 249.59M | 268.39M | 271.33M |
| Tax | 26.14M | 29.08M | 19.38M | 40.99M | 43.18M | 61.82M | 64.96M | 63.19M |
| Net profit | 69.72M | 76.07M | 49.97M | 110.03M | 151.04M | 187.78M | 203.43M | 208.15M |
| Basic EPS | 2 | 2 | 1 | 3 | 4 | 5 | 5 | 5 |
| Diluted EPS | 1.71 | 1.90 | 1.21 | 2.75 | 3.78 | 4.75 | 5.12 | 5.24 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 338.82M | 333.94M | 429.58M | 386.18M | 344.89M | 341.04M |
| Gross profit | 215.98M | 221.09M | 272.82M | 237.34M | 224.64M | 223.53M |
| Selling & admin expenses | 140.90M | 161.91M | 164.26M | 209.83M | 150.51M | 174.58M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 75.08M | 59.18M | 108.56M | 27.51M | 74.13M | 48.94M |
| Pretax profit | 73.41M | 54.13M | 107.56M | 36.24M | 75.21M | 48.25M |
| Tax | 18.01M | 12.93M | 24.28M | 7.97M | 18.50M | 11.36M |
| Net profit | 55.40M | 41.20M | 83.28M | 28.27M | 56.70M | 36.88M |
| Basic EPS | 1 | 1 | 2 | 1 | 1 | 1 |
| Diluted EPS | 1.32 | 0.99 | 2.05 | 0.88 | 1.35 | 0.95 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 571.60M | 573.30M | 600.72M | 709.72M | 787.72M | 839.03M | 926.40M | 1.03B |
| Cash & ST investments | 261.01M | 253.13M | 296.31M | 319.63M | 255.55M | 182.77M | 234.74M | 295.18M |
| Inventory | 161.78M | 167.81M | 158.82M | 198.91M | 289.98M | 371.86M | 371.92M | 351.38M |
| Total assets | 797.83M | 828.83M | 890.15M | 1.15B | 1.31B | 1.37B | 1.41B | 1.59B |
| Total current liabilities | 189.18M | 184.47M | 156.21M | 244.91M | 344.57M | 324.75M | 332.43M | 344.00M |
| Short-term debt | 23.16M | 17.68M | 19.70M | 21.93M | 33.84M | 39.96M | 56.01M | 70.50M |
| Long-term debt | 22.91M | 10.73M | 10.14M | 132.90M | 151.49M | 127.90M | 115.73M | 121.25M |
| Total liabilities | 212,083,000.00 | 219,834,000.00 | 187,695,000.00 | 407,032,000.00 | 520,396,000.00 | 477,159,000.00 | 468,616,000.00 | 481,224,000.00 |
| Total equity | 585.75M | 609.00M | 702.45M | 738.33M | 788.15M | 892.17M | 942.65M | 1.10B |
| Retained earnings | 448.73M | 474.64M | 503.57M | 560.66M | 620.10M | 693.85M | 763.24M | 828.91M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 911.07M | 986.99M | 990.74M | 1.03B | 997.77M | 950.97M |
| Cash & ST investments | 171.93M | 205.36M | 187.86M | 295.18M | 237.07M | 211.35M |
| Inventory | 395.89M | 425.35M | 388.30M | 351.38M | 369.63M | 375.58M |
| Total assets | 1.44B | 1.56B | 1.56B | 1.59B | 1.54B | 1.49B |
| Total current liabilities | 306.45M | 333.00M | 302.77M | 344.00M | 305.93M | 287.33M |
| Short-term debt | 57.14M | 107.53M | 72.49M | 70.50M | 60.97M | 55.32M |
| Long-term debt | 107.37M | 153.11M | 139.98M | 121.25M | 107.19M | 96.52M |
| Total liabilities | 433,006,000.00 | 504,996,000.00 | 460,155,000.00 | 481,224,000.00 | 430,231,000.00 | 399,406,000.00 |
| Total equity | 1.01B | 1.06B | 1.10B | 1.10B | 1.11B | 1.09B |
| Retained earnings | 780.34M | 787.03M | 826.96M | 828.91M | 846.63M | 838.59M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 63.04M | 76.45M | 64.99M | 119.59M | 73.03M | 105.77M | 187.64M | 214.90M |
| Depreciation & amortization | 11.03M | 8.73M | 9.07M | 12.70M | 22.54M | 17.33M | 28.36M | 25.30M |
| Free cash flow | 50.58M | 64.96M | 52.73M | -23.23M | -17.47M | 52.41M | 165.29M | 166.70M |
| Dividends paid | -26.29M | -34.58M | -20.81M | -31.69M | -63.74M | -80.05M | -96.03M | -102.72M |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | -15.39M | 0 | -13.87M |
| Ending cash balance | 193.14M | 133.42M | 169.68M | 168.39M | 104.71M | 88.46M | 125.43M | 158.09M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -7.36M | 11.87M | 63.86M | 146.53M | 85.00K | 45.58M |
| Depreciation & amortization | 5.93M | 6.36M | 6.55M | 6.47M | 5.80M | 5.83M |
| Free cash flow | -31.29M | -4.68M | 58.60M | 144.08M | -3.05M | 43.60M |
| Dividends paid | -25.70M | -25.69M | -25.70M | -25.63M | -25.64M | -25.62M |
| Stock buybacks / issuance | 0 | -2.04M | -5.43M | -6.40M | -3.94M | 0 |
| Ending cash balance | 96.62M | 151.45M | 110.40M | 158.09M | 79.86M | 169.70M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 12.21 | 13.16 | 7.61 | 15.78 | 20.35 | 23.20 | 22.76 | 20.72 |
| ROA %i | 6.82 | 7.40 | 4.45 | 8.59 | 9.86 | 11.40 | 11.82 | 11.24 |
| ROIC %i | 10.69 | 11.65 | 6.78 | 12.95 | 15.10 | 17.81 | 18.44 | 16.88 |
| 5-year avg ROE %i | 9.44 | 10.58 | 10.48 | 11.82 | 13.82 | 16.02 | 17.94 | 20.56 |
| EBIT margin %i | 14.57 | 15.04 | 13.23 | 17.49 | 18.20 | 19.80 | 19.02 | 18.72 |
| FCF / sales %i | 7.49 | 9.10 | 9.78 | -- | -- | 3.98 | 11.38 | 11.20 |
| Current ratioi | 3.02 | 3.11 | 3.85 | 2.90 | 2.29 | 2.58 | 2.79 | 2.99 |
| Quick ratioi | 2.10 | 2.11 | 2.72 | 2.00 | 1.40 | 1.35 | 1.55 | 1.85 |
| Debt / assetsi | 5.77 | 6.40 | 5.75 | 16.07 | 16.02 | 14.05 | 13.62 | 13.10 |
| LT debt / equityi | 5.12 | 7.56 | 5.88 | 28.35 | 28.51 | 21.79 | 18.28 | 15.58 |
| Interest coveragei | 38.18 | 50.00 | 36.20 | 54.46 | 54.96 | 23.18 | 35.30 | 38.44 |
| Revenue CAGR (3Y) %i | 12.97 | 11.05 | -3.04 | 9.19 | 15.05 | 34.71 | 18.20 | 11.06 |
| Net income CAGR (3Y) %i | 20.90 | 21.81 | -2.78 | 17.57 | 26.15 | 58.66 | 23.43 | 11.66 |
| FCF CAGR (3Y) %i | -- | 9.99 | 18.33 | -- | -- | -0.21 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 22.16 | 20.68 | 19.95 | 20.72 | 20.27 | 19.62 |
| ROA %i | 11.89 | 11.00 | 10.80 | 11.24 | 11.35 | 10.99 |
| ROIC %i | 18.44 | 16.60 | 16.14 | 16.88 | 16.74 | 15.96 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 19.04 | 18.74 | 19.09 | 18.72 | 18.75 | 18.16 |
| FCF / sales %i | 12.77 | 10.86 | 9.70 | 11.20 | 13.04 | 16.20 |
| Current ratioi | 2.97 | 2.96 | 3.27 | 2.99 | 3.26 | 3.31 |
| Quick ratioi | 1.57 | 1.54 | 1.86 | 1.85 | 1.91 | 1.83 |
| Debt / assetsi | 12.75 | 17.90 | 14.69 | 13.10 | 11.85 | 11.07 |
| LT debt / equityi | 16.05 | 20.49 | 18.07 | 15.58 | 13.82 | 12.59 |
| Interest coveragei | 36.93 | 31.22 | 36.13 | 38.44 | 39.27 | 49.96 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Fragrances and fragrance related products100.00%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.